Venetoclax Combined with FLAG-IDA Induction and Consolidation in Newly Diagnosed Acute Myeloid Leukemia

被引：0

作者：

Lachowiez, Curtis ^{[1
]}

Takahashi, Koichi ^{[2
]}

Loghavi, Sanam ^{[3
]}

Xiao, Lianchun ^{[4
]}

Kadia, Tapan ^{[2
]}

Adeoti, Maria ^{[2
]}

Short, Nicholas ^{[2
]}

Sasaki, Koji ^{[2
]}

Wang, Sa ^{[3
]}

Borthakur, Gautam ^{[2
]}

Issa, Ghayas ^{[2
]}

Maiti, Abhishek ^{[2
]}

Alvarado, Yesid ^{[2
]}

Pemmaraju, Naveen ^{[2
]}

Bravo, Guillermo Montalban ^{[2
]}

Masarova, Lucia ^{[2
]}

Yilmaz, Musa ^{[2
]}

Jain, Nitin ^{[2
]}

Andreeff, Michael ^{[2
]}

Jabbour, Elias ^{[2
]}

Garcia-Manero, Guillermo ^{[2
]}

Kornblau, Steven ^{[2
]}

Ravandi, Farhad ^{[2
]}

Konopleva, Marina ^{[2
]}

Kantarjian, Hagop ^{[2
]}

DiNardo, Courtney ^{[2
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USA

[2] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA

[3] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA

[4] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2021年 / 21卷

关键词：

induction chemotherapy; venetoclax; targeted therapy; acute myeloid leukemia;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

AML-204

引用

页码：S291 / S291

页数：1

共 50 条

[21] Safety and efficacy of FLAG-Ida-based therapy combined with venetoclax for the treatment for newly diagnosed and relapsed/refractory patients with AML - A systematic review
Sherban, A.
Fredman, D.
Shimony, S.
Yeshurun, M.
Raanani, P.
Stahl, M.
Gafter-Gvili, A.
Wolach, O.
LEUKEMIA RESEARCH, 2023, 133
[22] Venetoclax combined with daunorubicin and cytarabine (2 + 6) as induction treatment in adults with newly diagnosed acute myeloid leukemia: a phase 2, multicenter, single-arm trial
Xiaohui Suo
Fang Zheng
Dongmei Wang
Liyun Zhao
Jie Liu
Ling Li
Zhihua Zhang
Congcong Zhang
Yinling Li
Sisi Yang
Xuemei Zhao
Rui Shi
Yan Wu
Zongjiu Jiao
Jiaojie Song
Ling Zhang
Xinxiao Lu
Linyu Yuan
Sifeng Gao
Jilei Zhang
Xingli Zhao
Guanchen Bai
Kaiqi Liu
Yingchang Mi
Experimental Hematology & Oncology, 12
[23] Clinical experience with venetoclax in patients with newly diagnosed, relapsed, or refractory acute myeloid leukemia
Fleischmann, Maximilian
Scholl, Sebastian
Frietsch, Jochen J.
Hilgendorf, Inken
Schrenk, Karin
Hammersen, Jakob
Prims, Florian
Thiede, Christian
Hochhaus, Andreas
Schnetzke, Ulf
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (11) : 3191 - 3202
[24] Venetoclax Combining with Homoharringtonine,Daunorubicin and Cytarabine (HAD) As Induction Treatment in Newly Diagnosed Adult Acute Myeloid Leukemia Patients
Yan, Zhangsong
Li, Yang
Zhang, Bin
He, Jinsong
Li, Jiesi
Wei, Shuning
Wang, Qi
Li, Qiuling
Hu, Bo
Liu, Kaiqi
Mi, Yingchang
BLOOD, 2023, 142
[25] Venetoclax in combination with FLAG-IDA-based protocol for patients with acute myeloid leukemia: a real-world analysis
Wolach, Ofir
Frisch, Avraham
Shargian, Liat
Yeshurun, Moshe
Apel, Arie
Vainstein, Vladimir
Moshe, Yakir
Shimony, Shai
Amit, Odelia
Bar-On, Yael
Ofran, Yishai
Raanani, Pia
Nachmias, Boaz
Ram, Ron
ANNALS OF HEMATOLOGY, 2022, 101 (08) : 1719 - 1726
[26] Venetoclax in combination with FLAG-IDA-based protocol for patients with acute myeloid leukemia: a real-world analysis
Ofir Wolach
Avraham Frisch
Liat Shargian
Moshe Yeshurun
Arie Apel
Vladimir Vainstein
Yakir Moshe
Shai Shimony
Odelia Amit
Yael Bar-On
Yishai Ofran
Pia Raanani
Boaz Nachmias
Ron Ram
Annals of Hematology, 2022, 101 : 1719 - 1726
[27] Combination of cyclophosphamide and cytarabine as induction regimen for newly diagnosed adult acute myeloid leukemia
Liu, Qingguo
Gao, Hongye
Li, Junfan
Hu, Yimin
Wu, Lihua
Zhao, Xin
Li, Shangzhu
EJHAEM, 2020, 1 (01): : 79 - 85
[28] Venetoclax combined with daunorubicin and cytarabine (2+6) as induction treatment in adults with newly diagnosed acute myeloid leukemia: a phase 2, multicenter, single-arm trial
Suo, Xiaohui
Zheng, Fang
Wang, Dongmei
Zhao, Liyun
Liu, Jie
Li, Ling
Zhang, Zhihua
Zhang, Congcong
Li, Yinling
Yang, Sisi
Zhao, Xuemei
Shi, Rui
Wu, Yan
Jiao, Zongjiu
Song, Jiaojie
Zhang, Ling
Lu, Xinxiao
Yuan, Linyu
Gao, Sifeng
Zhang, Jilei
Zhao, Xingli
Bai, Guanchen
Liu, Kaiqi
Mi, Yingchang
EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2023, 12 (01)
[29] Individualizing Treatment for Newly Diagnosed Acute Myeloid Leukemia
Reville, Patrick K.
Kadia, Tapan
CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2020, 21 (04)
[30] Venetoclax in Combination with Azacitidine for the Treatment of Newly Diagnosed Acute Myeloid Leukemia: A Canadian Cost-Utility Analysis
Guinan, Kimberly
Mathurin, Karine
Au, Yunghan
Schuh, Andre C.
Bui, Cat N.
Chai, Xinglei
Lachaine, Jean
CURRENT ONCOLOGY, 2022, 29 (10) : 7524 - 7536

← 1 2 3 4 5 →